Cargando...
Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma
In daily clinical practice, there is a growing number of patients receiving new biological agents used in the treatment of malignancies. Ipilimumab is a fully humanized monoclonal antibody approved for patients with melanoma. It acts as an immune checkpoint inhibitor, binding and blocking cytotoxic...
Gardado en:
| Publicado en: | Front Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Media S.A.
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5891586/ https://ncbi.nlm.nih.gov/pubmed/29666602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00150 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|